<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 21 - FOOD AND DRUGS</title></head><body>
<span style="font-weight:bold;font-size:12pt;">21 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2011 Edition</span><br/>
<span style="font-size:10pt">Title 21 - FOOD AND DRUGS</span><br/>
<span style="font-size:10pt">CHAPTER 9 - FEDERAL FOOD, DRUG, AND COSMETIC ACT</span><br/>
<span style="font-size:10pt">SUBCHAPTER X - MISCELLANEOUS</span><br/>
<span style="font-size:10pt">Sec. 399a - Office of the Chief Scientist</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:21_399a  usckey:210000000039900000000000a00000000 currentthrough:20120103 documentPDFPage:445 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER X/Sec. 399a -->
<!-- itemsortkey:210AANL -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER X-MISCELLANEOUS!@!Sec. 399a -->
<!-- field-start:head -->
<h3 class="section-head">&sect;399a. Office of the Chief Scientist</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Establishment; appointment</h4>
<p class="statutory-body">The Secretary shall establish within the Office of the Commissioner an office to be known as the Office of the Chief Scientist. The Secretary shall appoint a Chief Scientist to lead such Office.</p>
<h4 class="subsection-head">(b) Duties of the Office</h4>
<p class="statutory-body">The Office of the Chief Scientist shall&mdash;</p>
<p class="statutory-body-1em">(1) oversee, coordinate, and ensure quality and regulatory focus of the intramural research programs of the Food and Drug Administration;</p>
<p class="statutory-body-1em">(2) track and, to the extent necessary, coordinate intramural research awards made by each center of the Administration or science-based office within the Office of the Commissioner, and ensure that there is no duplication of research efforts supported by the Reagan-Udall Foundation for the Food and Drug Administration;</p>
<p class="statutory-body-1em">(3) develop and advocate for a budget to support intramural research;</p>
<p class="statutory-body-1em">(4) develop a peer review process by which intramural research can be evaluated;</p>
<p class="statutory-body-1em">(5) identify and solicit intramural research proposals from across the Food and Drug Administration through an advisory board composed of employees of the Administration that shall include&mdash;</p>
<p class="statutory-body-2em">(A) representatives of each of the centers and the science-based offices within the Office of the Commissioner; and</p>
<p class="statutory-body-2em">(B) experts on trial design, epidemiology, demographics, pharmacovigilance, basic science, and public health; and</p>
<br class="Q04" />
<p class="statutory-body-1em">(6) develop postmarket safety performance measures that are as measurable and rigorous <!-- PDFPage:446 -->as the ones already developed for premarket review.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;1010, formerly &sect;910, as added Pub. L. 110&ndash;85, title VI, &sect;602, Sept. 27, 2007, 121 Stat. 898; renumbered &sect;1010, Pub. L. 111&ndash;31, div. A, title I, &sect;101(b)(2), June 22, 2009, 123 Stat. 1784.)</p>
<!-- field-end:sourcecredit -->


</body></html>